Financial Year |
March 31 2023 |
Monetary Funds |
17,306,627,158.22 |
Held-for-trading Financial Assets |
129,989,370.69 |
Notes Receivable |
-- |
Accounts Receivable |
8,922,166,833.35 |
Advances to Suppliers |
1,546,486,660.54 |
Other Receivables |
790,003,714.11 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
242,385,951.97 |
Inventories |
16,554,341,000.90 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
3,250,466,350.14 |
Total Current Assets |
51,837,224,937.73 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
509,553,182.11 |
Long-term Equity Investment |
8,484,088,546.58 |
Investment Properties |
-- |
Fixed Assetes |
26,797,127,924.90 |
Under-construction Projects |
21,592,748,835.64 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
4,040,065,101.74 |
R&D expenses |
-- |
Goodwill |
458,071,847.21 |
Long-Term Deferred and Prepaid Expenses |
90,966,952.72 |
Deferred Income Tax Assets |
700,932,037.74 |
Other Non-Current Assets |
4,682,797,790.28 |
Sub-Total of Non-Current Assets |
68,034,244,426.46 |
Total Assets |
119,871,469,364.19 |
Short-Term Loans |
13,605,939,653.91 |
Trading Financial liabilities |
50,634,462.21 |
Notes Payable |
11,853,593,602.01 |
Accounts Payable |
14,855,036,690.99 |
Accounts Received In Advance |
492,095,799.99 |
Employee Compensation Payable |
335,089,761.63 |
Taxes Payable |
565,177,468.72 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
5,032,284,102.65 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
6,713,754,617.48 |
Other Current Liabilities |
2,321,992,086.75 |
Sub-Total of Current Liabilities |
57,993,959,821.84 |
Long-term Loans |
13,857,501,227.19 |
Bonds Payable |
6,384,324,869.00 |
Long-Term Accounts Payable |
5,445,584,959.57 |
Special Payable |
-- |
Estimatied Liabilities |
85,635,782.68 |
Deferred Income Tax Liabilities |
382,994,799.19 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
26,851,357,663.10 |
Total Liabilities |
84,845,317,484.94 |
Paid-In Capital(Or Share Stock) |
1,599,464,709.00 |
Capital Surplus |
10,523,581,587.18 |
Surplus Reserve |
328,198,605.34 |
LESS:Treasury Stock |
621,464,554.50 |
Undistributed Profits |
12,928,059,969.21 |
Minority Stockholder's Interest |
7,848,391,131.91 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
27,177,760,747.34 |
Owner's Equity(Stockholder's Equity) |
35,026,151,879.25 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
119,871,469,364.19 |